Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 6, 2012

View Archived Issues

Rilotumumab does not improve efficacy of combination therapy in prostate cancer trial

Cixutumumab and ramucirumab studied in metastatic castration-resistant prostate cancer

FDA grants orphan drug status to Del Mar Pharmaceuticals product

Magnetic resonance techniques detect metabolic biomarker of low-grade glioma

Intellect Neurosciences provides pipeline update

Novo Nordisk completes phase I trial of novel oral insulin

Prima BioMed begins enrollment in CANVAS study

Merck KGaA claims new ALK5 inhibitors

Brazilian university patents new products with anticancer potential

Bayer Schering designs novel activators of soluble guanylate cyclase

OGX-427 shows signs of efficacy in phase II trial

Phase II trial assesses RO-4929097 in prostate cancer

Alpharadin available through new expanded access program

Pfizer designs novel liver X receptor modulators

Phase II GFT-505 study meets all efficacy objectives

Clinuvel Pharmaceuticals files MAA for erythropoietic protoporphyria treatment

Novel beta1-adrenoceptor ligands synthesized in U.K.

Novel PI3K inhibitors disclosed by Novartis

FDA accepts IND for Ziopharm product

FDA lifts partial clinical hold on hepatitis C therapy

FDA advisory committee sets date to review Marqibo NDA

Biogen Idec and Sobi release details of revised hemophilia program agreement

Oryzon choses drug candidate to begin preclinical testing for Huntington's disease

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...